Yuanhe Chencun secures three consecutive wins on the STAR Market—Junshi Biosciences and two other companies successfully pass the review.

2020-04-03

Recently, three companies from the mother fund portfolio managed by Yuanhe Chencun successfully passed the review on the STAR Market: Shanghai Junshi Biosciences Co., Ltd. (hereafter referred to as "Junshi Biosciences"), Beijing Shenzhou Cell Biotechnology Group Co., Ltd. (hereafter referred to as "Shenzhou Cell"), and Beijing Tianzhihang Medical Technology Co., Ltd. (hereafter referred to as "Tianzhihang").